Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain

M. J. Hurley, Deborah C Mash, P. Jenner

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Reverse transcription polymerase chain reaction (RT-PCR) was used to examine the expression of the cannabinoid CB1 receptor mRNA in post-mortem brain tissue obtained from normal subjects and patients dying with Parkinson's disease. CB1 receptor mRNA was detected in striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus, substantia nigra) brain regions. In parkinsonian tissue the level of CB1 receptor mRNA was decreased in the caudate nucleus, anterior dorsal putamen and external segment of the globus pallidus, but remained unchanged in the other brain areas examined. These results show that CB 1 receptor mRNA expression was altered in Parkinson's disease (though the effects of drug treatment can not be ruled out) and indicate that cannabinoid CB1 receptor mRNA expression was affected by alterations in dopaminergic systems.

Original languageEnglish
Pages (from-to)1279-1288
Number of pages10
JournalJournal of Neural Transmission
Volume110
Issue number11
DOIs
StatePublished - Nov 1 2003

Fingerprint

Cannabinoid Receptor CB1
Basal Ganglia
Messenger RNA
Brain
Globus Pallidus
Caudate Nucleus
Putamen
Parkinson Disease
Corpus Striatum
Nucleus Accumbens
Substantia Nigra
Reverse Transcription
Polymerase Chain Reaction
Pharmaceutical Preparations

Keywords

  • Basal ganglia
  • Cannabinoid CB
  • Parkinson's disease
  • Receptor mRNA
  • RT-PCR

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. / Hurley, M. J.; Mash, Deborah C; Jenner, P.

In: Journal of Neural Transmission, Vol. 110, No. 11, 01.11.2003, p. 1279-1288.

Research output: Contribution to journalArticle

Hurley, M. J. ; Mash, Deborah C ; Jenner, P. / Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. In: Journal of Neural Transmission. 2003 ; Vol. 110, No. 11. pp. 1279-1288.
@article{8afdb42e38b84addba2ae459744e56a7,
title = "Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain",
abstract = "Reverse transcription polymerase chain reaction (RT-PCR) was used to examine the expression of the cannabinoid CB1 receptor mRNA in post-mortem brain tissue obtained from normal subjects and patients dying with Parkinson's disease. CB1 receptor mRNA was detected in striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus, substantia nigra) brain regions. In parkinsonian tissue the level of CB1 receptor mRNA was decreased in the caudate nucleus, anterior dorsal putamen and external segment of the globus pallidus, but remained unchanged in the other brain areas examined. These results show that CB 1 receptor mRNA expression was altered in Parkinson's disease (though the effects of drug treatment can not be ruled out) and indicate that cannabinoid CB1 receptor mRNA expression was affected by alterations in dopaminergic systems.",
keywords = "Basal ganglia, Cannabinoid CB, Parkinson's disease, Receptor mRNA, RT-PCR",
author = "Hurley, {M. J.} and Mash, {Deborah C} and P. Jenner",
year = "2003",
month = "11",
day = "1",
doi = "10.1007/s00702-003-0033-7",
language = "English",
volume = "110",
pages = "1279--1288",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain

AU - Hurley, M. J.

AU - Mash, Deborah C

AU - Jenner, P.

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Reverse transcription polymerase chain reaction (RT-PCR) was used to examine the expression of the cannabinoid CB1 receptor mRNA in post-mortem brain tissue obtained from normal subjects and patients dying with Parkinson's disease. CB1 receptor mRNA was detected in striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus, substantia nigra) brain regions. In parkinsonian tissue the level of CB1 receptor mRNA was decreased in the caudate nucleus, anterior dorsal putamen and external segment of the globus pallidus, but remained unchanged in the other brain areas examined. These results show that CB 1 receptor mRNA expression was altered in Parkinson's disease (though the effects of drug treatment can not be ruled out) and indicate that cannabinoid CB1 receptor mRNA expression was affected by alterations in dopaminergic systems.

AB - Reverse transcription polymerase chain reaction (RT-PCR) was used to examine the expression of the cannabinoid CB1 receptor mRNA in post-mortem brain tissue obtained from normal subjects and patients dying with Parkinson's disease. CB1 receptor mRNA was detected in striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus, substantia nigra) brain regions. In parkinsonian tissue the level of CB1 receptor mRNA was decreased in the caudate nucleus, anterior dorsal putamen and external segment of the globus pallidus, but remained unchanged in the other brain areas examined. These results show that CB 1 receptor mRNA expression was altered in Parkinson's disease (though the effects of drug treatment can not be ruled out) and indicate that cannabinoid CB1 receptor mRNA expression was affected by alterations in dopaminergic systems.

KW - Basal ganglia

KW - Cannabinoid CB

KW - Parkinson's disease

KW - Receptor mRNA

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=0345490815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345490815&partnerID=8YFLogxK

U2 - 10.1007/s00702-003-0033-7

DO - 10.1007/s00702-003-0033-7

M3 - Article

C2 - 14628192

AN - SCOPUS:0345490815

VL - 110

SP - 1279

EP - 1288

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 11

ER -